Roquefort Therapeutics proposes sale of Midkine portfolio to Pleiades Pharma

Roquefort Therapeutics plc, a London Stock Exchange (LSE:ROQ) listed biotech company, has announced its plan to divest its subsidiary, Lyramid Pty Ltd, to Pleiades Pharma ... Read More